Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Rare Germline Variants and Genetic Susceptibility to Pleural Mesothelioma: Moving Beyond DNA Repair. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1038/s41467-018-05467-z
10.1038/s41467-018-05467-z · External reference
10.1016/j.envint.2023.108165
10.1016/j.envint.2023.108165 · External reference
10.1016/s0140-6736(20)32714-8
10.1016/s0140-6736(20)32714-8 · External reference
10.1016/j.annonc.2022.01.074
10.1016/j.annonc.2022.01.074 · External reference
A randomised phase III study of bevacizumab and carboplatin-pemetrexed chemotherapy with or without atezolizumab as first-line treatment for advanced pleural mesothelioma: results of the ETOP 13-18 BEAT-meso trial
10.1016/j.annonc.2024.12.014 · 2025 · External reference
10.1038/s41416-022-01979-0
10.1038/s41416-022-01979-0 · External reference
Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations
10.1016/j.jtho.2022.03.014 · 2022 · External reference
Clinical practice guidelines for the diagnosis and surveillance of BAP1 tumour predisposition syndrome
10.1038/s41431-023-01448-z · 2023 · External reference
Novel Germline Mutations in DNA Damage Repair in Patients with Malignant Pleural Mesotheliomas
10.1016/j.jtho.2019.12.111 · 2020 · External reference
10.1016/j.lungcan.2023.03.008
10.1016/j.lungcan.2023.03.008 · External reference
10.1016/j.canlet.2016.05.011
10.1016/j.canlet.2016.05.011 · External reference
Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma
10.1016/j.canlet.2017.06.028 · 2017 · External reference
Treatment of Pleural Mesothelioma: ASCO Guideline Update
10.1200/jco-24-02425 · 2025 · External reference
Malignant pleural mesothelioma: Germline variants in DNA repair genes may steer tailored treatment
10.1016/j.ejca.2021.12.023 · 2022 · External reference
10.1093/carcin/bgu227
10.1093/carcin/bgu227 · External reference
10.1073/pnas.1821510116
10.1073/pnas.1821510116 · External reference
10.1200/jco.2018.79.0352
10.1200/jco.2018.79.0352 · External reference
BAP1-loss in mesothelioma: molecular mechanisms and clinical opportunities
10.1038/s41388-025-03672-x · 2026 · External reference
Phase II Trial of the PARP Inhibitor, Niraparib, in BAP1 and Other DNA Damage Response Pathway-Deficient Neoplasms.
2024 · External reference
EZH2 inhibitor tazemetostat in patients with relapsed or refractory, BAP1-inactivated malignant pleural mesothelioma: a multicentre, open-label, phase 2 study
10.1016/s1470-2045(22)00277-7 · 2022 · External reference
Combination of EZH2 and ATM inhibition in BAP1-deficient mesothelioma
10.1038/s41416-024-02661-3 · 2024 · External reference
10.1038/s41588-018–0183-z
10.1038/s41588-018–0183-z · External reference
10.1038/s41568-023-00599-x
10.1038/s41568-023-00599-x · External reference
Individuals who deviate from polygenic expectation are enriched for damaging variants in genes linked to rare disease
10.1016/j.ajhg.2026.05.013 · 2026 · External reference
10.1038/s41467-026-72185-2
10.1038/s41467-026-72185-2 · External reference
10.1016/j.ejca.2010.07.025
10.1016/j.ejca.2010.07.025 · External reference
Blood cell DNA methylation biomarkers in preclinical malignant pleural mesothelioma: The EPIC prospective cohort
10.1002/ijc.34339 · 2023 · External reference
Peripheral Blood DNA Methylation as Potential Biomarker of Malignant Pleural Mesothelioma in Asbestos-Exposed Subjects
10.1016/j.jtho.2018.10.163 · 2019 · External reference
10.3390/cancers15010125
10.3390/cancers15010125 · External reference
10.1002/ijc.70316
10.1002/ijc.70316 · External reference
10.1007/s10238-026-02058-x
10.1007/s10238-026-02058-x · External reference
10.3390/jpm14101025
10.3390/jpm14101025 · External reference
10.1158/1055-9965.epi-13-0119-t
10.1158/1055-9965.epi-13-0119-t · External reference
10.1038/gim.2015.30
10.1038/gim.2015.30 · External reference
10.1111/cge.14516
10.1111/cge.14516 · External reference
10.1016/j.ajhg.2012.06.007
10.1016/j.ajhg.2012.06.007 · External reference
10.1093/biostatistics/kxv033
10.1093/biostatistics/kxv033 · External reference
10.1093/bioinformatics/btw079
10.1093/bioinformatics/btw079 · External reference
10.1371/journal.pone.0061253
10.1371/journal.pone.0061253 · External reference
Driver Mutations in Uveal Melanoma: Associations With Gene Expression Profile and Patient Outcomes
10.1001/jamaophthalmol.2016.0903 · 2016 · External reference
10.1073/pnas.2019652117
10.1073/pnas.2019652117 · External reference
10.1136/jmedgenet-2019-106657
10.1136/jmedgenet-2019-106657 · External reference
10.1002/jha2.557
10.1002/jha2.557 · External reference
10.1038/s41431-024-01611-0
10.1038/s41431-024-01611-0 · External reference
Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma
10.1200/jco.2018.78.5204 · 2018 · External reference
Germline Variants Incidentally Detected via Tumor-Only Genomic Profiling of Patients With Mesothelioma
10.1001/jamanetworkopen.2023.27351 · 2023 · External reference
Novel LRRK2 mutations and other rare, non-BAP1-related candidate tumor predisposition gene variants in high-risk cancer families with mesothelioma and other tumors
10.1093/hmg/ddab138 · 2021 · External reference
10.1038/s41525-019-0087-6
10.1038/s41525-019-0087-6 · External reference
10.3389/fgene.2014.00441
10.3389/fgene.2014.00441 · External reference
Different Fumarate Hydratase Gene Variants Are Associated With Distinct Cancer Phenotypes
2021 · External reference
Wnt/beta-catenin signaling in cancers and targeted therapies
10.1038/s41392-021-00701-5 · 2021 · External reference
10.1016/j.molcel.2021.04.002
10.1016/j.molcel.2021.04.002 · External reference
10.3389/fimmu.2024.1365975
10.3389/fimmu.2024.1365975 · External reference
10.1186/s12967-019-2058-1
10.1186/s12967-019-2058-1 · External reference
10.1038/s41467-018-05467-z
10.1038/s41467-018-05467-z · External reference
